Evidence map›Paper›PMID 25087874›Full record

ArticleMolecular cell2014

Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis.

Ravi K Singh, Zheng Xia, Christopher S Bland, Auinash Kalsotra, Marissa A Scavuzzo, Tomaz Curk, Jernej Ule, Wei Li, Thomas A Cooper

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 127 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Ancestral intronic splicing regulatory elements in the SCNbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Characterization of Alternative Splicing in High-Risk Wilms' Tumors.International journal of molecular sciences · 2024
    Article
  15. Article
  16. Article
  17. The Molecular and Biological Function of MEF2D in Leukemia.Advances in experimental medicine and biology · 2024
    Review
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Ravi K Singh *Departments of Pathology and Immunology, Baylor College of Medicine, Medicine, Houston, Texas 77030, USA.
Zheng Xia *Departments of Molecular and Cellular Biology, Baylor College of Medicine, Medicine, Houston, Texas 77030, USA.
Christopher S BlandThe Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Medicine, Houston, Texas 77030, USA.
Auinash KalsotraDepartments of Pathology and Immunology, Baylor College of Medicine, Medicine, Houston, Texas 77030, USA.
Marissa A ScavuzzoDepartments of Pathology and Immunology, Baylor College of Medicine, Medicine, Houston, Texas 77030, USA.
Tomaz CurkUniversity of Ljubljana, Faculty of Computer and Information Science, Trẑaŝka cesta 25, SI-1000 Ljubljana.
Jernej UleDepartment of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
Wei LiDepartments of Molecular and Cellular Biology, Baylor College of Medicine, Medicine, Houston, Texas 77030, USA.
Thomas A CooperDepartments of Pathology and Immunology, Baylor College of Medicine, Medicine, Houston, Texas 77030, USA.
Baylor College of Medicine · USNational Hospital for Neurology and Neurosurgery · GBUniversity of Ljubljana · SI

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTIONU54HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI DEMAYO, FRANCESCO JOHN · 1998 to 2013
$19.9M
Initiative for Maximizing Student Development (IMSD) ProgramR25GM056929 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PEREIRA, FRED A · 1998 to 2023
$12.4M
MOLECULAR PATHOGENESIS OF MYOTONIC DYSTROPHYR01AR045653 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI COOPER, THOMAS A · 1999 to 2018
$8.3M
TROPONIN T ALTERNATIVE SPLICING IN EMBRYONIC HEARTR01HL045565 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI COOPER, THOMAS A · 1996 to 2018
$5.5M
Transcriptome processing networks in skeletal muscle: mechanisms and functionsR01AR060733 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI COOPER, THOMAS A · 2011 to 2023
$4.0M
Computational and Experimental Modeling of Epigenetic DNA MethylationR01HG007538 · NHGRI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LI, WEI · 2014 to 2018
$1.9M
GROWTH AND DIFFERENTIATION IN EUKARYOTEST32HD007495 · NICHD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI KINTNER, CHRISTOPHER ROBERT · 1995 to 2009
$1.6M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
TRANSGENIC ANIMAL--COREP30HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI GLASSER, STANLEY R · 1985 to 1997
–
Medical Research Council MC_U105185858NCI NIH HHS CA125123NCI NIH HHS P30 CA125123NCRR NIH HHS RR024574NCRR NIH HHS S10 RR024574NHGRI NIH HHS R01 HG007538NHGRI NIH HHS R01HG007538NHLBI NIH HHS R01 HL045565NHLBI NIH HHS R01HL045565NIAID NIH HHS AI036211NIAID NIH HHS P30 AI036211NIAMS NIH HHS R01 AR045653NIAMS NIH HHS R01AR045653NIAMS NIH HHS R01 AR060733NIAMS NIH HHS R01AR060733NICHD NIH HHS HD007495NICHD NIH HHS P30 HD007495NICHD NIH HHS T32 HD007495NIDDK NIH HHS DK56338NIDDK NIH HHS P30 DK056338NIGMS NIH HHS R25 GM056929
6 · The paper itself

Abstract

Alternative splicing plays important regulatory roles during periods of physiological change. During development, a large number of genes coordinately express protein isoform transitions regulated by alternative splicing; however, the mechanisms that coordinate splicing and the functional integration of the resultant tissue-specific protein isoforms are typically unknown. Here we show that the conserved Rbfox2 RNA binding protein regulates 30% of the splicing transitions observed during myogenesis and is required for the specific step of myoblast fusion. Integration of Rbfox2-dependent splicing outcomes from RNA-seq with Rbfox2 iCLIP data identified Mef2d and Rock2 as Rbfox2 splicing targets. Restored activities of Mef2d and Rock2 rescued myoblast fusion in Rbfox2-depleted cultures, demonstrating functional cooperation of protein isoforms generated by coordinated alterative splicing. The results demonstrate that coordinated alternative splicing by a single RNA binding protein modulates transcription (Mef2d) and cell signaling (Rock2) programs to drive tissue-specific functions (cell fusion) to promote a developmental transition.

Indexed as

Alternative SplicingAnimalsCell LineChlorocebus aethiopsConserved SequenceCOS CellsGene Expression RegulationHEK293 CellsHumansMEF2 Transcription FactorsMiceMuscle DevelopmentMyoblastsOrgan SpecificityProtein Isoformsrho-Associated KinasesMEF2 Transcription FactorsProtein Isoformsrho-Associated KinasesRNARNA-Binding Proteins

Identifiers

PMID25087874
PMCPMC4142074
OpenAlexW2110580958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.